Aligos Therapeutics, Inc. ALGS
4.75 USD +0.15 (+3.26%)
At closeNov 3, 2026, 6:22 PM EST
4.73 -0.02 -0.52%
After hours · Nov 3, 6:22 PM ET
4.65 Day range 4.95
3.98 52-week range 13.69
- YTD
- -49.03%
- 1 year
- -36.92%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 2.19M | 3.94M | 15.53M | 13.91M | 4.36M | |
| 2.19M | 3.94M | 15.53M | 13.91M | 4.36M | |
| -87.98M | -89.15M | -88.13M | -97.58M | -128.32M | |
| -24.19M | -131.21M | -87.68M | -96.05M | -128.33M | |
| -2.45 | -20.94 | -34.20 | -56.00 | -80.00 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 18.41M | 37.11M | 135.77M | 81.46M | 186.98M | |
| 88.53M | 70.09M | 151.53M | 146.69M | 235.37M | |
| 34.99M | 99.07M | 59.45M | 42.79M | 50.64M | |
| 5.25M | 8.38M | 11.14M | 12.57M | 14.46M | |
| 53.55M | -28.97M | 92.08M | 103.90M | 184.73M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -82.50M | -80.74M | -79.00M | -79.39M | -115.66M | |
| -37.83M | -18.28M | 44.98M | -26.29M | 3.02M | |
| 101.64M | 355.00K | 88.33M | 164.00K | 78.68M | |
| -437.00K | -130.00K | -19.00K | -943.00K | -892.00K | |
| -18.69M | -98.67M | 54.31M | -105.52M | -33.96M |